Urinary Side Effects of Guanfacine in Children
Urinary incontinence is a documented but uncommon urinary side effect of guanfacine in children, occurring in less than 3% of patients according to FDA labeling data. 1
Primary Urinary Side Effects
The FDA drug label explicitly lists urinary incontinence as an adverse reaction that occurred in controlled trials, though at a rate of 3% or less. 1 Additionally, the following urinary symptoms have been reported:
- Nocturia (nighttime urination)
- Urinary frequency (increased urination)
These urinary effects are classified under the "URINARY SYSTEM" category in postmarketing surveillance data. 1
Clinical Context and Mechanism
Guanfacine is an alpha-2 adrenergic agonist that causes decreased blood pressure and heart rate as its primary cardiovascular effects. 2 This mechanism may contribute to urinary symptoms through effects on bladder tone and sphincter control.
Important Clinical Considerations
Paradoxical therapeutic effect: Interestingly, one case report documented successful treatment of nocturnal enuresis (bedwetting) in a 10-year-old girl with ADHD using guanfacine monotherapy at 1 mg/day. 3 This suggests the urinary effects of guanfacine may be bidirectional and patient-specific.
Frequency of occurrence: Urinary incontinence was specifically noted as a reason for dropout in one 12-week placebo-controlled study, though it remained uncommon. 1
Most Common Side Effects (For Comparison)
The predominant side effects of guanfacine in children are:
- Somnolence (38.6% in meta-analysis) 4
- Dry mouth (up to 54% at higher doses) 1
- Fatigue (15.2%) 4
- Headache (20.5%) 4
Somnolence is the most clinically significant side effect, causing early discontinuation in 44% of patients who stop within 70 days of treatment. 5
Monitoring Recommendations
When prescribing guanfacine for ADHD in children, specifically inquire about:
- Changes in urinary frequency or urgency
- New onset bedwetting or daytime incontinence
- Nocturia
These urinary symptoms should prompt dose adjustment or consideration of alternative ADHD medications if they impair quality of life.